Moderna Unveils Q1 2026 Financials And Business Updates
01 May 2026 //
FIRSTWORD PHARMA
Moderna In Talks With FDA Over Phase 4 Covid Vaccine Data
01 May 2026 //
ENDPOINTS
Moderna Exceeds Revenue Expectations, Faces Litigation Impact
01 May 2026 //
BIOSPACE
CureVac Sues Moderna For COVID-19 Vaccine Patent Infringement
26 Apr 2026 //
FIRSTWORD PHARMA
Moderna wins EU approval for combined flu, COVID shot
22 Apr 2026 //
REUTERS
Moderna To Present Data At 2026 ASCO Conference
21 Apr 2026 //
PHARMIWEB
Sanofi`s new COVID shot tops Moderna`s mNexspike in safety trial
20 Apr 2026 //
PRESS RELEASE
Moderna To Unveil Mrna-4359 Cancer Therapy Data At AACR 2026
17 Apr 2026 //
PHARMIWEB
Moderna To Release Q1 2026 Financial Results On May 1
15 Apr 2026 //
PHARMIWEB
Moderna To Unveil Revaccination Data For Seasonal Flu Vaccine
06 Apr 2026 //
PHARMIWEB
EU Backs Approval for Moderna`s combined COVID and flu Vaccines
28 Feb 2026 //
REUTERS
FDA Backs Moderna`s mRNA-1010, Revolutionizing Seasonal Flu Shots
24 Feb 2026 //
EXPRESSPHARMA
Trump Met With Makary Before FDA`s Moderna Walkback
19 Feb 2026 //
FIERCE BIOTECH
Moderna To Present At Upcoming Conferences In March 2026
19 Feb 2026 //
PHARMIWEB
FDA Accepts Filing For Moderna Flu Vaccine After Swift Rethink
19 Feb 2026 //
FIERCE BIOTECH
Moderna Rejects Mrna Vaccine Amid Global Advanced Therapies Drive
17 Feb 2026 //
BIOSPACE
Moderna Secures EU Approval For COVID-19 Vaccine Mnexspike
17 Feb 2026 //
PHARMIWEB
Moderna`s New Covid Vaccine Mnexspike Wins European Approval
17 Feb 2026 //
INDPHARMAPOST
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy
16 Feb 2026 //
BIOSPACE
Moderna R&D Spend Shrunk 31% In 2025 Amid Major Pipeline Reorg
13 Feb 2026 //
FIERCE PHARMA
Vaccine makers facing increased volatility, uncertainty at FDA
13 Feb 2026 //
FIERCE PHARMA
Moderna Unveils Q4 2025 Financials And Business Updates
13 Feb 2026 //
PHARMIWEB
HHS Backs Prasad Amid Moderna Flu Shot Blowback
12 Feb 2026 //
BIOSPACE
Flu Vaccine Rejection Imperils Moderna`s Breakeven Plans
12 Feb 2026 //
BIOSPACE
Moderna Forms Long-Term mRNA Vaccine Supply Pact With Mexico
10 Feb 2026 //
FIERCE PHARMA
Moderna Hit With FDA Refusal-To-File Letter For mRNA Flu Shot
10 Feb 2026 //
FIERCE BIOTECH
Moderna`s Latest CMO Steps Down After Barely A Year
30 Jan 2026 //
FIERCE BIOTECH
Recordati, Moderna Ink Deal for mRNA-3927 in Propionic Acidemia
29 Jan 2026 //
GLOBENEWSWIRE
Moderna Won’t Run Phase III Vaccine Trials
27 Jan 2026 //
BLOOMBERG
Moderna To Release Q4 2025 Financial Results On February 13, 2026
26 Jan 2026 //
PHARMIWEB
Merck, Moderna Sustain 49% Melanoma Risk Reduction At 5 Years
22 Jan 2026 //
FIERCE BIOTECH
Moderna Achieves 2025 Revenue Target With Lower Operating Costs
12 Jan 2026 //
BIOSPACE
Bayer Sues Moderna, J&J And Pfizer/Biontech Over COVID Vax Tech
07 Jan 2026 //
FIERCE PHARMA
Moderna secures up to $54.3M funding for bird flu vaccine
18 Dec 2025 //
REUTERS
Moderna To Present At 44th J.P. Morgan Healthcare Conference
17 Dec 2025 //
PHARMIWEB
EMA CHMP Backs Moderna`s mNEXSPIKE COVID Vaccine
15 Dec 2025 //
PHARMIWEB
Moderna`s $500M pact with Nanexa to improve injectables delivery
11 Dec 2025 //
FIERCE BIOTECH
Moderna secures $1.5B loan, eyes cash breakeven in 2028
21 Nov 2025 //
FIERCE PHARMA
Moderna Winds Down 3 mRNA Programs
20 Nov 2025 //
FIERCE BIOTECH
Moderna Showcases Pipeline Progress And Business Strategy
20 Nov 2025 //
PHARMIWEB
Moderna To Bolster US Production Ability With $140M Plant
19 Nov 2025 //
FIERCE PHARMA
Moderna Doses 1st Patient In Ph 1/2 T-Cell Engager Myeloma Study
03 Nov 2025 //
PHARMIWEB
Moderna Scraps Congenital Virus Program After Vax Fails Ph. 3
24 Oct 2025 //
FIERCE BIOTECH
Moderna-Backed Campaign Takes A Shot At Boosting Vaccine Uptake
22 Oct 2025 //
FIERCE PHARMA
Companies Tackle Swift Production Of Custom mRNA Therapies Fast
21 Oct 2025 //
BIOSPACE
Moderna Showcases Flu Vaccine Candidates At IDWEEK 2025
19 Oct 2025 //
PHARMIWEB
Moderna Unveils Positive Early Results For Cancer Antigen Therapy
12 Oct 2025 //
PHARMIWEB
Former Moderna Executives Launch $325M Venture Capital Fund
09 Oct 2025 //
FIERCE BIOTECH
Moderna Launches Advanced Manufacturing And R&D Site In UK
27 Sep 2025 //
PHARMIWEB
Moderna`s mNEXSPIKE Shows Strong Response Against LP.8.1 Variant
23 Sep 2025 //
ACCESSWIRE
Moderna Delivers First Made-in-Canada mRNA Vaccines
19 Sep 2025 //
PHARMAWEB
Moderna, Alnylam Settle COVID-19 Vaccine Patent Dispute
19 Sep 2025 //
FIERCE PHARMA
Moderna Settles Alnylam Patent Lawsuits Over Covid Vaccine
19 Sep 2025 //
REUTERS
Biotech Vet Robert Langer & Son Launch New VC
18 Sep 2025 //
FIERCE BIOTECH
Moderna Reveals Strong Human Immune Response to Updated COVID-19
16 Sep 2025 //
PHARMAWEB
GSK Adds Moderna`s Next-Gen Covid Shot to MRNA Patent Lawsuit
05 Sep 2025 //
FIERCE PHARMA
Moderna to Present Data at Inborn Errors of Metabolism Congress
02 Sep 2025 //
ACCESSWIRE
Pfizer, Moderna score updated COVID Vaccine Approvals From FDA
29 Aug 2025 //
FIERCE PHARMA
Moderna to Speak at Conferences in September 2025
21 Aug 2025 //
PHARMAWEB
Moderna Reports Q2 2025 Financial Results, Updates on Business
01 Aug 2025 //
ACCESSWIRE

Market Place
Sourcing Support